ÐÇ¿ÕÓéÀÖ¹ÙÍø Seasonal Flu Vaccine Effectiveness Studies

What to know

ÐÇ¿ÕÓéÀÖ¹ÙÍø conducts studies each flu season to help determine how well flu vaccines are working. These vaccine effectiveness (VE) studies help regularly assess the value of flu vaccination as a public health intervention. The results of vaccine effectiveness studies can vary based on the study design, the outcome(s) measured, the population studied, and the season studied.

U.S. flu vaccine effectiveness networks

ÐÇ¿ÕÓéÀÖ¹ÙÍø has been working with researchers at universities and hospitals since the 2003-2004 flu season to estimate how well flu vaccines work through observational studies using laboratory-confirmed flu as the outcome. Over the past few years, ÐÇ¿ÕÓéÀÖ¹ÙÍø has conducted VE studies using multiple vaccine effectiveness networks. More information on ÐÇ¿ÕÓéÀÖ¹ÙÍø's vaccine effectiveness networks and studies is available at ÐÇ¿ÕÓéÀÖ¹ÙÍø's Influenza Vaccine Effectiveness Networks.

Results from prior flu seasons

The overall, adjusted vaccine effectiveness estimates for flu seasons from 2004-2025 are noted in the chart below. (Estimates are typically adjusted for study site, age, sex, underlying medical conditions, and days from illness onset to enrollment.)

Effectiveness of Seasonal Flu Vaccines from the 2009-2025 Flu Seasons

The vaccine effectiveness estimates included in the chart and tables below are vaccine effectiveness estimates from multiple VE networks.

Chart showing the level of seasonal flu vaccine effectiveness 2009 through 2025
Chart showing the level of seasonal flu vaccine effectiveness 2009 through 2025
2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 2018-19 2019-20 2020-21* 2021-22 2022-23 2023-24 2024-25††
Adj. Overall VE (%) 56 60 47 49 52 19 48 40 38 29 39 Not enough data to compute 36 30 44 56

*2020-2021 flu vaccine effectiveness was not estimated due to low influenza virus circulation during the 2020-2021 flu season.

A point estimate is a single value that is used to estimate an unknown population parameter. Point estimates are used in statistics to make inferences about population parameters based on sample data. More information is available at How Flu Vaccine Effectiveness and Efficacy are Measured.

Overall VE

Adjusted vaccine effectiveness estimates for influenza seasons from 2004-2025

Influenza Season

Reference

Study Site(s)

No. of Patients

Adjusted Overall VE (%)

95% CI

2004-05*

WI

762

10

-36, 40

2005-06*

WI

346

21

-52, 59

2006-07*

WI

871

52

22, 70

2007-08*

WI

1,914

37

22, 49

2008-09*

Unpublished

WI, MI, NY, TN

6,713

41

30, 50

2009-10*

WI, MI, NY, TN

6,757

56

23, 75

2010-11*

WI, MI, NY, TN

4,757

60

53, 66

WI, MI, PA, TX, WA

4,771

47

36, 56

WI, MI, PA, TX, WA

6,452

49

43, 55

WI, MI, PA, TX, WA

5,999

52

44, 59

WI, MI, PA, TX, WA

9,311

19

10, 27

WI, MI, PA, TX, WA

6,879

48

41, 55

WI, MI, PA, TX, WA 7,410

40

32, 46

WI, MI, PA, TX, WA 8,436

38

31, 43

WI, MI, PA, TX, WA 10,041

29

21, 35

2019-20

WI, MI, PA, TX, WA 8,845

39

32, 44

2020-21**

n/a n/a n/a

n/a

2021-22

CA, MI, PA, TN, TX, WA, WI 4,312 36 21, 48

2022-23

MI, PA, TX, WA, AZ, MO, OH 2,561 30 -9, 54

2023-24***

AZ, MI, MO, PA, OH, TX, WA 9,061 44 36, 51

2024-25††

Frutos 2025 MN, WI, UT, CA, OR, WA, IN, CO 139,558 56 54, 58

*From 2004-2005 through 2010-2011, the Flu VE Network also enrolled inpatients.

Vaccine effectiveness (VE) estimates for the 2008-2009 flu season have not been published.

**2020-2021 flu vaccine effectiveness was not estimated due to low influenza virus circulation during the 2020-2021 flu season.

Number of patients used in VE calculation.

***Overall VE was calculated for this table to be consistent with what has been reported historically and is available for comparison with historical estimates. All other 2023-2024 VE estimates are reported by age group.

†† VE estimates for 2024-2025 flu season are preliminary.

Supporting research